Atul Pande - 12 Apr 2023 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Role: Director
Signature: /s/ Eva Renee Barnett, attorney-in-fact for Atul Pande
Issuer symbol: IMVT
Transactions as of: 12 Apr 2023
Net transactions value: $0
Form type: 4
Filing time: 14 Apr 2023, 16:37:22 UTC
Previous filing: 04 Oct 2022
Next filing: 22 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IMVT	Common Stock	Award	$0	+12,523	+15%	$0.000000	95,508	12 Apr 2023	Direct	F1, F2
holding	IMVT	Common Stock						20,000	12 Apr 2023	By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IMVT	Stock Option (right to buy)	Award	$0	+16,260		$0.000000	16,260	12 Apr 2023	Common Stock	16,260	$14.70	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares underlying restricted stock units awards ("RSUs").
F2	The RSUs vest in their entirety one year after the date of grant on April 12, 2024, subject to the Reporting Person's continued service to the Issuer as of such date; provided that the Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.
F3	The shares underlying the options vest one year after the date of grant on April 12, 2024, subject to the Reporting Person's continuous service to the Issuer as of such date.